Zobrazeno 1 - 10 of 104 pro vyhledávání: '"Kosheleff AR"'
1
Akademický článek
Impact of Viloxazine Extended-Release Capsules (Qelbree ® ) on Select Cytochrome P450 Enzyme Activity and Evaluation of CYP2D6 Genetic Polymorphisms on Viloxazine Pharmacokinetics.
Autor: Wang Z; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA. zwang@supernus.com., Liranso T; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA., Maldonado-Cruz Z; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA., Kosheleff AR; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA., Nasser A; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA.
Publikováno v: Clinical drug investigation [Clin Drug Investig] 2024 May; Vol. 44 (5), pp. 303-317. Date of Electronic Publication: 2024 Apr 10.
Zobrazit plný text záznamu
2
Akademický článek
Advanced Model-based Approach to Evaluate Human Plasma, Cerebrospinal Fluid, and Neuronal mTORC1 Activation Biomarkers After NV-5138 Administration in Healthy Volunteers.
Autor: Nasser A; Supernus Pharmaceuticals, Inc., Rockville, Maryland., Randall Owen J; Navitor Pharmaceuticals, Inc., Boston, Massachusetts., Gomeni R; Pharmacometrica, Lieu-dit Longcol, La Fouillade, France., Kosheleff AR; Supernus Pharmaceuticals, Inc., Rockville, Maryland., Portelli J; Supernus Pharmaceuticals, Inc., Rockville, Maryland., Adeojo LW; Supernus Pharmaceuticals, Inc., Rockville, Maryland., Hughes TE; Navitor Pharmaceuticals, Inc., Boston, Massachusetts. Electronic address: thughes@navitorpharma.com.
Publikováno v: Clinical therapeutics [Clin Ther] 2024 Mar; Vol. 46 (3), pp. 217-227. Date of Electronic Publication: 2024 Mar 13.
Zobrazit plný text záznamu
3
Akademický článek
Functional Impairments Associated With ADHD in Adulthood and the Impact of Pharmacological Treatment.
Autor: Kosheleff AR; Supernus Pharmaceuticals, Inc., Rockville, MD, USA., Mason O; Attention MD, Grand Rapids, MI, USA and Michigan State University College of Human Medicine, East Lansing, MI, USA., Jain R; Texas Tech University School of Medicine, Midland, TX, USA., Koch J; Supernus Pharmaceuticals, Inc., Rockville, MD, USA., Rubin J; Supernus Pharmaceuticals, Inc., Rockville, MD, USA.
Publikováno v: Journal of attention disorders [J Atten Disord] 2023 May; Vol. 27 (7), pp. 669-697. Date of Electronic Publication: 2023 Mar 06.
Zobrazit plný text záznamu
4
Akademický článek
A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
Autor: Nasser A; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA. anasser@supernus.com., Hull JT; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA., Chaturvedi SA; Formerly with Supernus Pharmaceuticals, Inc. 9715 Key West Avenue, Rockville, MD, USA., Liranso T; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA., Odebo O; Formerly with Supernus Pharmaceuticals, Inc. 9715 Key West Avenue, Rockville, MD, USA., Kosheleff AR; Formerly with Supernus Pharmaceuticals, Inc. 9715 Key West Avenue, Rockville, MD, USA., Fry N; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA., Cutler AJ; Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, USA., Rubin J; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA., Schwabe S; Formerly with Supernus Pharmaceuticals, Inc. 9715 Key West Avenue, Rockville, MD, USA., Childress A; Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas, NV, USA.
Publikováno v: CNS drugs [CNS Drugs] 2022 Aug; Vol. 36 (8), pp. 897-915. Date of Electronic Publication: 2022 Jul 27.
Zobrazit plný text záznamu
5
Akademický článek
Impact of a High-Fat Meal and Sprinkled Administration on the Bioavailability and Pharmacokinetics of Viloxazine Extended-Release Capsules (Qelbree TM ) in Healthy Adult Subjects.
Autor: Wang Z; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA., Kosheleff AR; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA., Adeojo LW; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA., Odebo O; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA., Liranso T; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA., Schwabe S; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA., Nasser A; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, USA. anasser@supernus.com.
Publikováno v: European journal of drug metabolism and pharmacokinetics [Eur J Drug Metab Pharmacokinet] 2022 Jan; Vol. 47 (1), pp. 69-79. Date of Electronic Publication: 2021 Oct 15.
Zobrazit plný text záznamu
6
Akademický článek
Population Pharmacokinetics of Viloxazine Extended-Release Capsules in Pediatric Subjects With Attention Deficit/Hyperactivity Disorder.
Autor: Nasser A; Supernus Pharmaceuticals Inc., Rockville, Maryland, USA., Gomeni R; Pharmacometrica, Lieu-dit Longcol, La Fouillade, France., Wang Z; Supernus Pharmaceuticals Inc., Rockville, Maryland, USA., Kosheleff AR; Supernus Pharmaceuticals Inc., Rockville, Maryland, USA., Xie L; Supernus Pharmaceuticals Inc., Rockville, Maryland, USA., Adeojo LW; Supernus Pharmaceuticals Inc., Rockville, Maryland, USA., Schwabe S; Supernus Pharmaceuticals Inc., Rockville, Maryland, USA.
Publikováno v: Journal of clinical pharmacology [J Clin Pharmacol] 2021 Dec; Vol. 61 (12), pp. 1626-1637. Date of Electronic Publication: 2021 Aug 08.
Zobrazit plný text záznamu
7
Akademický článek
Impact of Paroxetine, a Strong CYP2D6 Inhibitor, on SPN-812 (Viloxazine Extended-Release) Pharmacokinetics in Healthy Adults.
Autor: Wang Z; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Kosheleff AR; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Adeojo LW; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Odebo O; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Adewole T; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Qin P; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Maletic V; Department of Psychiatry/Behavioral Science, University of South Carolina School of Medicine, Greenville, South Carolina, USA., Schwabe S; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Nasser A; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA.
Publikováno v: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2021 Nov; Vol. 10 (11), pp. 1365-1374. Date of Electronic Publication: 2021 May 04.
Zobrazit plný text záznamu
8
Akademický článek
Evaluating the likelihood to be helped or harmed after treatment with viloxazine extended-release in children and adolescents with attention-deficit/hyperactivity disorder.
Autor: Nasser A; Supernus Pharmaceuticals, Inc., Rockville, MD, USA., Kosheleff AR; Supernus Pharmaceuticals, Inc., Rockville, MD, USA., Hull JT; Supernus Pharmaceuticals, Inc., Rockville, MD, USA., Liranso T; Supernus Pharmaceuticals, Inc., Rockville, MD, USA., Qin P; Supernus Pharmaceuticals, Inc., Rockville, MD, USA., Busse GD; Supernus Pharmaceuticals, Inc., Rockville, MD, USA., Fava M; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA., Maletic V; Department of Psychiatry/Behavioral Science, University of South Carolina School of Medicine, Greenville, SC, USA., Rubin J; Supernus Pharmaceuticals, Inc., Rockville, MD, USA., Lopez F; Children's Developmental Center, Winter Park, FL, USA.
Publikováno v: International journal of clinical practice [Int J Clin Pract] 2021 Aug; Vol. 75 (8), pp. e14330. Date of Electronic Publication: 2021 May 26.
Zobrazit plný text záznamu
9
Akademický článek
Translating Attention-Deficit/Hyperactivity Disorder Rating Scale-5 and Weiss Functional Impairment Rating Scale-Parent Effectiveness Scores into Clinical Global Impressions Clinical Significance Levels in Four Randomized Clinical Trials of SPN-812 (Viloxazine Extended-Release) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
Autor: Nasser A; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Kosheleff AR; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Hull JT; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Liranso T; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Qin P; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Busse GD; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., O'Neal W; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA., Fava M; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA., Faraone SV; Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, New York, USA., Rubin J; Supernus Pharmaceuticals, Inc., Rockville, Maryland, USA.
Publikováno v: Journal of child and adolescent psychopharmacology [J Child Adolesc Psychopharmacol] 2021 Apr; Vol. 31 (3), pp. 214-226. Date of Electronic Publication: 2021 Feb 17.
Zobrazit plný text záznamu
10
Akademický článek
Evaluation of Effects of Food Addiction in Rat Model: An Experimental Study.
Autor: SHANMUGAPRIYA, S1 somasundaram999@rediffmail.com, RAJEE, S SARANYA2, SUBHASHINI, R3
Publikováno v: Journal of Clinical & Diagnostic Research. Jul2024, Vol. 18 Issue 7, p6-10. 5p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje